Cancer Science投稿须知

期刊简介

《Cancer Science》是由Wiley-Blackwell出版社于2003年创办的英文国际期刊（ISSN: 1349-7006，E-ISSN: 1349-7006），该期刊长期致力于肿瘤学领域的创新研究，主要研究方向为ONCOLOGY。作为SCIE收录期刊（JCR分区 Q1，中科院 2区），本刊采用OA开放获取模式（OA占比1%），以发表肿瘤学领域等方向的原创性研究为核心（研究类文章占比92.41%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在316篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cancer Science审稿周期约为 17 Weeks 。该刊近年未被列入国际预警名单，年发文量约316篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
否是否预警
SCIE 期刊收录
316 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
是	否	医学 2区	ONCOLOGY 肿瘤学 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 2区	ONCOLOGY 肿瘤学 2区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	78 / 322	75.9%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	79 / 322	75.62%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：9.9

SJR：1.625

SNIP：1.091

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q1	61 / 404	85%
大类：Medicine 小类：Cancer Research	Q1	52 / 230	77%

期刊发文

Distinct mechanisms of dysfunctional antigen-presenting DCs and monocytes by single-cell sequencing in multiple myeloma
Author: Jiang, Jinxing; Xiang, Jing; Chen, Mengping; Wan, Yike; Zhong, Lu; Han, Xiaofeng; Chen, Xiaotong; Wang, Junying; Xiao, Fei; Liu, Jia; Li, Hua; Huang, Honghui; Hou, Jian

Journal: CANCER SCIENCE. 2023; Vol. , Issue , pp. -. DOI: 10.1111/cas.15800
Targeting the PTP1B-Bcr-Abl1 interaction for the degradation of T315I mutant Bcr-Abl1 in chronic myeloid leukemia
Author: Elgehama, Ahmed; Wang, Yixuan; Yu, Ying; Zhou, Lin; Chen, Zhixiu; Wang, Liwei; Sun, Lijun; Gao, Jian; Yu, Biao; Shen, Yan; Xu, Qiang

Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 247-258. DOI: 10.1111/cas.15580
Hypoxia-induced CXC chemokine ligand 14 expression drives protumorigenic effects through activation of insulin-like growth factor-1 receptor signaling in glioblastoma
Author: Wei, Sung-Tai; Chiang, Jung-Ying; Wang, Hwai-Lee; Lei, Fu-Ju; Huang, Yen-Chih; Wang, Chi-Chung; Cho, Der-Yang; Hsieh, Chia-Hung

Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 174-186. DOI: 10.1111/cas.15587
METTL3-mediated m6A mRNA contributes to the resistance of carbon-ion radiotherapy in non-small-cell lung cancer
Author: Xu, Xiaofeng; Zhang, Peiru; Huang, Yangle; Shi, Weizhong; Mao, Jingfang; Ma, Ningyi; Kong, Lin; Guo, Lin; Liu, Jinlong; Chen, Jian; Lu, Renquan

Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 105-114. DOI: 10.1111/cas.15590
Novel hKDR mouse model depicts the antiangiogenesis and apoptosis-promoting effects of neutralizing antibodies targeting vascular endothelial growth factor receptor 2
Author: Cao, Yuan; Sun, Chunyun; Huo, Guitao; Wang, Huiyu; Wu, Yong; Wang, Fei; Liu, Susu; Zhai, Shijie; Zhang, Xiao; Zhao, Haoyang; Hu, Meiling; Gu, Wenda; Yang, Yanwei; Wang, Sanlong; Liang, Chunnan; Lyu, Jianjun; Lu, Tiangong; Wang, Youchun; Xie, Liangzhi; Fan, Changfa

Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 115-128. DOI: 10.1111/cas.15594
N6-methyladenosine-modified HOTAIRM1 promotes vasculogenic mimicry formation in glioma
Author: Wu, Zhangyi; Lin, Yihai; Wei, Nan

Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 129-141. DOI: 10.1111/cas.15578
CXC chemokine ligand-10 promotes the accumulation of monocyte-like myeloid-derived suppressor cells by activating p38 MAPK signaling under tumor conditions
Author: Sun, Yingying; Mo, Yan; Jiang, Shu; Shang, Chao; Feng, Yunpeng; Zeng, Xianlu

Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 142-151. DOI: 10.1111/cas.15598
Multiomics analyses and machine learning of nuclear receptor coactivator 6 reveal its essential role in hepatocellular carcinoma
Author: Fang, Yinghao; Xu, Yuyan; Liao, Wei; Ji, Tao; Yu, Linyuan; Li, Longhai; Pan, Mingxin; Yang, Dinghua

Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 75-90. DOI: 10.1111/cas.15577

Cancer Science

癌症科学

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询